Patents Cannot Be Blamed for Inequitable Access to COVID-19 Vaccines

被引：1

作者：

Duarte, R. A. I. L. D. O. ^{[1
]}

Khan, Hasan I. R. F. A. N. ^{[2
]}

Luna, A. L. E. J. A. N. D. R. O. ^{[3
]}

Amin, R. A. M. A. D. A. N. ^{[4
]}

Yadav, C. H. A. R. U. L. ^{[5
]}

Storz, U. L. R. I. C. H. ^{[6
]}

机构：

[1] Paralegal & Int Affairs Coordinator Camelier Advog, Sao Paulo, Brazil

[2] Attorney United Trademark & Patent Serv Lahore, Lahore, Pakistan

[3] Partnerat Olivares & Compania SC, Mexico City, Mexico

[4] Eldib & Co Attorneys Lawin Cairo, Cairo, Egypt

[5] Partner Obhan & Asso ciates Advocates & Patent Age, New Delhi, India

[6] Michalski Huettermannand Partner Patent Attorneys, Dusseldorf, Germany

来源：

BIOTECHNOLOGY LAW REPORT | 2022年 / 41卷 / 02期

关键词：

COVID; patent; vaccine; RNA;

D O I：

10.1089/blr.2022.29265.us

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

In view of the inequitable distribution of COVID-19 vaccines, several initiatives have been discussed to waive respective patent rights. This article provides a fact-based multinational study on patent rights protecting BioNTech-Pfizer's vaccine BNT162b2. We conclude that although there actually is a vaccine shortage in many countries, patents cannot be blamed as the scapegoat for said situation.

引用

页码：86 / 92

页数：7

共 19 条

[1]

[Anonymous], Gamaleya Institute, which has developed the Sputnik V vector vaccine, has filed international patent application, Patent No. [WO2021002776A1, 2021002776]

[2]

BURGER L, 2021, REUTERS 0617

[3]

Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]

[4]

Cavazzini Anna, 2021, RELEASE VACCINE PATE

[5] Politics of Vaccine Nationalism in India: Global and Domestic Implications [J].

Chatterjee, Niladri ;

Mahmood, Zaad ;

Marcussen, Eleonor .

FORUM FOR DEVELOPMENT STUDIES, 2021, 48 (02) :357-369

[6]

Friede R., 2021, WHO

[7]

Gulliver T, 2003, South China Morning Post

[8]

Hoerr I, 2000, EUR J IMMUNOL, V30, P1

[9] Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA [J].

Karikó, K ;

Buckstein, M ;

Ni, HP ;

Weissman, D .

IMMUNITY, 2005, 23 (02) :165-175

[10]

McKenzie David, 2021, THE CNN

← 1 2 →